BIOCOMPONENTS AND BIOPROSPECTS OF ETHANOLIC EXTRACT OF TERMITOMYCES HEIMII

  • Payel Mitra
  • Narayan Chandra MANDAL
  • Krishnendu Acharya Molecular and Applied Mycology and Plant Pathology Laboratory Department of Botany University of Calcutta 35, Ballygunge Circular Road Kolkata, 700019 West Bengal (India)

Abstract

Objective: The objective was to select, set up and initiate the health screening services in the community pharmacy, to design and develop patient

data collection form and patient identity card, to implement health screening services in a selected community pharmacy and to evaluate the health
screening services data.
Methods: The study was a prospective, investigational and community interventional study, conducted for a period of 10 months from May 2008 to
February 2009.
Results: A total of 98 patients and 24 customers under risk factors were screened during the study. Out of which 58 (59.18%) patients were diabetic
with hypertensive, 26 (26.53%) were hypertensive and 14 (14.28%) were diabetic. The systolic and diastolic blood pressure, random blood sugar
and body mass index values of the screened patients reveals the need for the provision of health screening services in the community pharmacy by a
pharmacist. Various demographic factors such as age, gender, occupation, economic status, educational background, periodic check-up showed equal
impact of pharmacist involvement and need to provide these services in the community pharmacy.
Conclusion: This study suggest that there is ample scientific evidence showing that certain risk factors pre-dispose individuals to development of
diabetes and hypertension, there is sufficient evidence to conclude that community screening is a cost effective approach to reduce the morbidity and
mortality associated with these diseases in healthy individuals. Community screening programs may provide a means to enhance public awareness
regarding seriousness of diabetes and hypertension and its complications.

Keywords: Health screening services, Community pharmacy, Diabetes, Hypertension.

 

Author Biography

Krishnendu Acharya, Molecular and Applied Mycology and Plant Pathology Laboratory Department of Botany University of Calcutta 35, Ballygunge Circular Road Kolkata, 700019 West Bengal (India)
Molecular and Applied Mycology and Plant Pathology LaboratoryDepartment of Botany

References

1. Wiedenmayer K, Summers RS, Mackie CA, Gous AG, Everard M. Developing Pharmacy Practice a Focus on Patient Care: Handbook. Geneva: World Health Organization; 2006. p. 3-6.
2. Health Screening. NTUC Income your partner for a better life. Available from: http://www.income.com.sg/enqform. [Last accessed on 2007 Oct 19].
3. Patil KV, Dharmalingam M, Kanakatte PK. Influence of socio-economic factors on diabetic care in India. International Diabetes Federation Congress. 18th Paris-France: Le Palais des Congres; 2003. p. 24-9.
4. The Royal Pharmaceutical Society of Great Britain. Practice Guidance on the Care of People with Diabetes. 3rd ed. Chichester, UK: Wiley & Sons Ltd.; 2004.
5. Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (home study). J Gen Intern Med 2005;20(12):1091-6.
6. McManus RJ, Mant J. Community pharmacies for detection and control of hypertension. J Hum Hypertens 2001;15(8):509-10.
7. Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc (Wash) 2003;43(1):50-5.8. Pharmacy-Based Hypertension Management Model: Protocol and Guidelines. CINDI/Euro Pharm Forum Project WHO Regional Office for Europe; 2004. p. 1-32.
9. Hersberger KE, Botomino A, Mancini M, Bruppacher R. Sequential screening for diabetes - Evaluation of a campaign in Swiss community pharmacies. Pharm World Sci 2006;28(3):171-9.
10. Improving Blood Pressure Management in Patients Diabetes: Available from: http://www.clinicaltrials.gov/ct. [Last accessed on 2007 Oct 19].
11. Moffat T. Point of care testing in a community pharmacy. Pharm J 2001;267:267-8.
12. Dugan BD. Enhancing community pharmacy through advanced pharmacy practice experiences. Am J Pharm Educ 2006;70(1):21.
13. Berger C. Screening of diabetes mellitus in burgandy. 18th International Diabetes Federation Congress, Paris, France; 2003. p. 24-9.
14. Tara Healthcare. Innovators in Irish Healthcare. Available from: http://www.tarahealth.com. [Last accessed on 2008 Nov]
15. The Royal Pharmaceutical Society of Great Britain. Diagnostic Testing in Community Pharmacy [Internet]. London. RPSGB. 2008. [cited on 2008]. Available from: http://www.rpharms.com/home/home.asp.
16. Harrison B, Hawksworth G, Hetherington L. Diagnostic testing and screening in community pharmacy. Pharm J 1992;249:226-37.
17. Lewis R, Jenkins C. A review of developments in diagnostic screening by community pharmacists. Community Pharm 2002;Vol. 12:34-5.
Statistics
314 Views | 393 Downloads
How to Cite
Mitra, P., N. Chandra MANDAL, and K. Acharya. “BIOCOMPONENTS AND BIOPROSPECTS OF ETHANOLIC EXTRACT OF TERMITOMYCES HEIMII”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 8, no. 3, May 2015, pp. 331-4, https://innovareacademics.in/journals/index.php/ajpcr/article/view/5804.
Section
Original Article(s)